Conversation

Notices

1. Ars Technica (arstechnica@mastodon.social)'s status on Tuesday, 31-Oct-2023 01:33:00 JST Ars Technica

   FDA warns of infection risk from 26 big-brand eye drops; stop using immediately

   No infections yet linked, but FDA found contamination in manufacturing facility.

   https://arstechnica.com/health/2023/10/fda-warns-of-infection-risk-from-26-big-brand-eye-drops-stop-using-immediately/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

   • Kid Mania (clintruin@mastodon.social)'s status on Tuesday, 31-Oct-2023 01:44:04 JST Kid Mania

     in reply to

     @arstechnica
     🤦♂️ jfc

   • Simon Lucy (simon_lucy@mastodon.social)'s status on Tuesday, 31-Oct-2023 02:09:30 JST Simon Lucy

     in reply to

     @arstechnica

     This is old news or another facility has an infection.

   • Gorgeous na Shock! (indigoparadox@mastodon.social)'s status on Tuesday, 31-Oct-2023 04:02:28 JST Gorgeous na Shock!

     in reply to

     @arstechnica I had dry eyes a couple weeks ago and thought I should buy some eyedrops. At the time, I remembered the Visene recall earlier this year and thought, "lol, I guess I won't buy that brand."

     In the end, I got distracted and forgot to buy any and my eyes got better on their own.

     Anyway, what a society, eh?

   • Jimmy Havok (jhavok@mastodon.social)'s status on Tuesday, 31-Oct-2023 05:12:51 JST Jimmy Havok

     in reply to

     @arstechnica 26 brands of eyedrops made in the same facility...this is a problem of monopolism. Fake branding, no difference except the label on the package. Any problem affects the whole product sector.

   • Shadowbottle (shadowbottle@mastodon.social)'s status on Tuesday, 31-Oct-2023 21:41:57 JST Shadowbottle

     in reply to

     @arstechnica weird, it’s like defunding and starving federal institutions could be a bad thing. Huh.